Overview

Meropenem Versus Meropenem Plus Glycopeptide in Patients With Febrile Neutropenia After Allogenic Blood Stem Cell Transplantation

Status:
Completed

Trial end date:
2009-04-01

Target enrollment:

Participant gender:

Summary

Observational study to compare the treatment in neutropenic patients after allogenic blood stem cell transplantation, with meropenem or meropenem plus glycopeptide.

Details

Lead Sponsor:

PETHEMA Foundation

Treatments:

Meropenem
Teicoplanin
Thienamycins
Vancomycin